The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment outcomes for metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) following docetaxel (D) for hormone sensitive disease.
 
Andrew Lachlan Schmidt
Travel, Accommodations, Expenses - Merck
 
Angelyn Anton
No Relationships to Disclose
 
Shirley S. Wong
No Relationships to Disclose
 
Arun Azad
Honoraria - Amgen; Astellas Pharma; Bayer; Janssen; Novartis; Pfizer; Telix Pharmaceuticals; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Novartis
Research Funding - Astellas Pharma; Merck Serono (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Merck Serono; Sanofi
 
Edmond Michael Kwan
Honoraria - Ipsen; Janssen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Pfizer
 
Lavinia Anne Spain
Research Funding - Ventana Medical Systems (Inst)
 
Javier Torres
Travel, Accommodations, Expenses - Merck
 
Arunbalaji Muthusamy
No Relationships to Disclose
 
Phillip Parente
No Relationships to Disclose
 
Francis Parnis
Consulting or Advisory Role - Astellas Medivation; Ipsen; Janssen Oncology; Pfizer
Travel, Accommodations, Expenses - Amgen; Astellas Medivation; Ipsen
 
Jeffrey C. Goh
Stock and Other Ownership Interests - Immutep
Consulting or Advisory Role - AstraZeneca; Tesaro
Speakers' Bureau - Ipsen; Janssen; Mundipharma; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca
 
Anthony M. Joshua
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
David William Pook
Honoraria - Astellas Pharma; Ipsen; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme (Inst); Pfizer (Inst)
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Pfizer
 
Peter Gibbs
Honoraria - Amgen; Merck; MSD Oncology; Roche; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst); Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - Servier
 
Ben Tran
Honoraria - Amgen; Astellas Pharma; Janssen-Cilag; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Janssen-Cilag; MSD Oncology; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb; Genentech (Inst); Janssen-Cilag (Inst); Janssen-Cilag (Inst); Merck Sharp & Dohme; Merck Sharp & Dohme; Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Andrew James Weickhardt
Honoraria - Eisai; Merck Sharp & Dohme
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme
Speakers' Bureau - Astellas Pharma
Research Funding - Merck
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Merck Sharp & Dohme